RBB Brief 5 discusses the controversial issue of excess pricing as an abuse in the context of the UK Competition Act case involving Napp Pharmaceuticals
Our experience and expertise means our clients have the best chance of success before competition authorities and courts.
We have unrivalled experience across the full range of issues presented by competition law and related associated litigation.
Articles
All Articles- RBB comments on Competition Commission’s Draft Guidance on OIPs
